241 related articles for article (PubMed ID: 31239676)
1. Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity.
Chen Y; Gu J; Liu J; Tong L; Shi F; Wang X; Wang X; Yu D; Wu H
Int J Nanomedicine; 2019; 14():4211-4227. PubMed ID: 31239676
[No Abstract] [Full Text] [Related]
2. Inner ear delivery of dexamethasone using injectable silk-polyethylene glycol (PEG) hydrogel.
Yu D; Sun C; Zheng Z; Wang X; Chen D; Wu H; Wang X; Shi F
Int J Pharm; 2016 Apr; 503(1-2):229-37. PubMed ID: 26972377
[TBL] [Abstract][Full Text] [Related]
3. A single dose of dexamethasone encapsulated in polyethylene glycol-coated polylactic acid nanoparticles attenuates cisplatin-induced hearing loss following round window membrane administration.
Sun C; Wang X; Zheng Z; Chen D; Wang X; Shi F; Yu D; Wu H
Int J Nanomedicine; 2015; 10():3567-79. PubMed ID: 25999718
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone loaded nanoparticles exert protective effects against Cisplatin-induced hearing loss by systemic administration.
Sun C; Wang X; Chen D; Lin X; Yu D; Wu H
Neurosci Lett; 2016 Apr; 619():142-8. PubMed ID: 26971701
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of cisplatin ototoxicity by otoprotective effects of nanoencapsulated curcumin and dexamethasone in a guinea pig model.
Salehi P; Akinpelu OV; Waissbluth S; Peleva E; Meehan B; Rak J; Daniel SJ
Otol Neurotol; 2014 Aug; 35(7):1131-9. PubMed ID: 24841915
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin-induced ototoxicity: effect of intratympanic dexamethasone injections.
Hill GW; Morest DK; Parham K
Otol Neurotol; 2008 Oct; 29(7):1005-11. PubMed ID: 18716567
[TBL] [Abstract][Full Text] [Related]
7. Effect of intratympanic dexamethasone administration on cisplatin-induced ototoxicity in adult guinea pigs.
Shafik AG; Elkabarity RH; Thabet MT; Soliman NB; Kalleny NK
Auris Nasus Larynx; 2013 Feb; 40(1):51-60. PubMed ID: 22884636
[TBL] [Abstract][Full Text] [Related]
8. Future opportunities in preventing cisplatin induced ototoxicity.
van den Berg JH; Beijnen JH; Balm AJ; Schellens JH
Cancer Treat Rev; 2006 Aug; 32(5):390-7. PubMed ID: 16781082
[TBL] [Abstract][Full Text] [Related]
9. Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs.
Yumusakhuylu AC; Yazici M; Sari M; Binnetoglu A; Kosemihal E; Akdas F; Sirvanci S; Yuksel M; Uneri C; Tutkun A
Int J Pediatr Otorhinolaryngol; 2012 Mar; 76(3):404-8. PubMed ID: 22261612
[TBL] [Abstract][Full Text] [Related]
10. Systemic dexamethasone for the prevention of cisplatin-induced ototoxicity.
Waissbluth S; Salehi P; He X; Daniel SJ
Eur Arch Otorhinolaryngol; 2013 May; 270(5):1597-605. PubMed ID: 22907029
[TBL] [Abstract][Full Text] [Related]
11. A silk-based hydrogel containing dexamethasone and lipoic acid microcrystals for local delivery to the inner ear.
Xiong H; Zhang P; Wang D; Zhou Z; Sun J; Diao M
Colloids Surf B Biointerfaces; 2024 May; 237():113855. PubMed ID: 38513298
[TBL] [Abstract][Full Text] [Related]
12. Novel synthetic protective compound, KR-22335, against cisplatin-induced auditory cell death.
Shin YS; Song SJ; Kang S; Hwang HS; Jung YS; Kim CH
J Appl Toxicol; 2014 Feb; 34(2):191-204. PubMed ID: 23297007
[TBL] [Abstract][Full Text] [Related]
13. The Sustained-Exposure Dexamethasone Formulation OTO-104 Offers Effective Protection against Cisplatin-Induced Hearing Loss.
Fernandez R; Harrop-Jones A; Wang X; Dellamary L; LeBel C; Piu F
Audiol Neurootol; 2016; 21(1):22-9. PubMed ID: 26789647
[TBL] [Abstract][Full Text] [Related]
14. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK.
Lee JS; Kang SU; Hwang HS; Pyun JH; Choung YH; Kim CH
Toxicol Lett; 2010 Dec; 199(3):308-16. PubMed ID: 20883750
[TBL] [Abstract][Full Text] [Related]
15. A novel synthetic compound, 3-amino-3-(4-fluoro-phenyl)-1H-quinoline-2,4-dione, inhibits cisplatin-induced hearing loss by the suppression of reactive oxygen species: in vitro and in vivo study.
Shin YS; Song SJ; Kang SU; Hwang HS; Choi JW; Lee BH; Jung YS; Kim CH
Neuroscience; 2013 Mar; 232():1-12. PubMed ID: 23246618
[TBL] [Abstract][Full Text] [Related]
16. FDA-Approved Tedizolid Phosphate Prevents Cisplatin-Induced Hearing Loss Without Decreasing Its Anti-tumor Effect.
Yao Z; Xiao Y; Li W; Kong S; Tu H; Guo S; Liu Z; Ma L; Qiao R; Wang S; Chang M; Zhao X; Zhang Y; Xu L; Sun D; Fu X
J Assoc Res Otolaryngol; 2024 Jun; 25(3):259-275. PubMed ID: 38622383
[TBL] [Abstract][Full Text] [Related]
17. Alpha-lipoic acid protects against cisplatin-induced ototoxicity via the regulation of MAPKs and proinflammatory cytokines.
Kim J; Cho HJ; Sagong B; Kim SJ; Lee JT; So HS; Lee IK; Kim UK; Lee KY; Choo YS
Biochem Biophys Res Commun; 2014 Jun; 449(2):183-9. PubMed ID: 24796665
[TBL] [Abstract][Full Text] [Related]
18. Round window application of D-methionine provides complete cisplatin otoprotection.
Korver KD; Rybak LP; Whitworth C; Campbell KM
Otolaryngol Head Neck Surg; 2002 Jun; 126(6):683-9. PubMed ID: 12087338
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of apocynin on cisplatin-induced ototoxicity in an auditory cell line and in zebrafish.
Choi J; Im GJ; Chang J; Chae SW; Lee SH; Kwon SY; Chung AY; Park HC; Jung HH
J Appl Toxicol; 2013 Feb; 33(2):125-33. PubMed ID: 22147442
[TBL] [Abstract][Full Text] [Related]
20. Uptake mechanism of furosemide-loaded pegylated nanoparticles by cochlear cell lines.
Youm I; Youan BB
Hear Res; 2013 Oct; 304():7-19. PubMed ID: 23747541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
